Zhongchao Inc. (ZCMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
ZCMD POWR Scores
- ZCMD scores best on the value dimension, with a value rank ahead of 81.53% of US stocks.
- ZCMD's strongest trending metric is stability; it's been moving down over the last 109 days.
- ZCMD's current lowest rank is in the stability metric (where it is better than 20.64% of US stocks).
ZCMD Stock Summary
- ZCMD's went public 1.19 years ago, making it older than only 0.46% of listed US stocks we're tracking.
- For ZCMD, its debt to operating expenses ratio is greater than that reported by just 7.37% of US equities we're observing.
- With a year-over-year growth in debt of -65.41%, Zhongchao Inc's debt growth rate surpasses only 4.59% of about US stocks.
- Stocks that are quantitatively similar to ZCMD, based on their financial statements, market capitalization, and price volatility, are JOUT, BRC, ASTE, DAO, and EFOI.
- ZCMD's SEC filings can be seen here. And to visit Zhongchao Inc's official web site, go to www.izcmd.com.
ZCMD Stock Price Chart Interactive Chart >
ZCMD Price/Volume Stats
| Current price | $1.69 | 52-week high | $5.25 |
| Prev. close | $1.72 | 52-week low | $1.59 |
| Day low | $1.68 | Volume | 113,100 |
| Day high | $1.72 | Avg. volume | 1,295,180 |
| 50-day MA | $1.75 | Dividend yield | N/A |
| 200-day MA | $1.85 | Market Cap | 30.56M |
Zhongchao Inc. (ZCMD) Company Bio
Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.
Latest ZCMD News From Around the Web
Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment LevelZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform ("Platform") built and operated by the Company. |
Zhongchao (NASDAQ:ZCMD) May Have Issues Allocating Its CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst... |
Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient ManagementZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, announced the establishment of a new subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. ("Zhongxin Ningxia") under Shanghai Zhongxin Medical Technology Co., Ltd., a subsidiary of the Company. Zhongxin Ningxia will build an internet hospital ("Zhongxin Internet Hospital") focusing on inpatient m |
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education ServicesZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV) ("AbbVie"). AbbVie is a research-based global biopharmaceutical company. Pursuant to an agreement to facilitate such cooperation, Zhongchao and AbbV |
Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene ShanghaiZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the on-going one-year joint project of leukemia diagnosis and treatment courses (the "Project") that the Company has been hosting with Beijing Bethune Charitable Foundation ("Bethune Foundation") and BeiGene Pharmaceutical (Shanghai) Co., Ltd. ("BeiGene Shanghai"), a subsidiary of BeiGene, Ltd. (NASDAQ: BGNE; |
ZCMD Price Returns
| 1-mo | N/A |
| 3-mo | -2.31% |
| 6-mo | -18.75% |
| 1-year | -40.70% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -0.59% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...